Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib Neuro-Oncology, Published online on January 22, 2010. DOI: 10.1093/neuonc/nop051.
2. 2010 Tumor microvasculature and microenvironment: Novel insights through intravital imaging in pre-clinical models Microcirculation (in press).
3. 2010 In vivo wide-area cellular imaging by side-view endomicroscopy Nature Methods 7:303-5 (2010).
4. 2010 Phase II study of cediranib, an oral pan- VEGF receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma J. Clinical Oncology (accepted).
5. 2010 Optical methods in vascular biology and medicine J Biomed Opt. 15:011001 (2010).
6. 2010 p53 Controls Radiation-induced Gastrointestinal Syndrome in Mice Independent of Apoptosis. Science 327:593-6 (2010).
7. 2010 Compact Biocompatible Quantum Dots via RAFTMediated Synthesis of Imidazole-Based Random Copolymer Ligand. ScJ Am Chem Soc. 132:472-83
8. 2010 InAs(ZnCdS) Quantum Dots Optimized for Biological Imaging in the Near-Infrared J Am Chem Soc. 132: 470-1 (2010).
9. 2010 Biomarkers of antiangiogenic therapy: How do we move from candidate biomarkers to valid biomarkers? Journal of Clinical Oncology 28:183-5 (2010).
10. 2010 Intravital microsopy of normal and diseased tissues in the mouse In: Live Cell Imaging: A Laboratory Manual, 2nd Edition, Chpater 26, pp 475-521 (R. D. Goldman, J. R. Swedlow and D. L. Specter, Eds.), CSH Press, Cold Spring Harbor, NY (2010).
11. 2010 Coronary plaque neovascularization and hemorrhage: a potential target for plaque stabilization? JACC Cardiovasc Imaging. 3:41-4 (2010).
12. 2010 In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model Neuro-Oncology 12:341-50
13. 2009 Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivo Biophysical Journal 97: 330-6 (2009).
14. 2009 VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation PLoSOne 4(9): e6525 (Published online on September 18, 2009).
15. 2009 VEGFR1 activity-independent metastasis formation Nature 461(7262): E4 (Published online on September 17, 2009
16. 2009 Direct evidence that bevacizumab, an anti-VEGF antibody, SDF1a, CXCR4, CXCL6 and neuropilin 1 in rectal cancer patients Cancer Research 69:7905-10 (2009).
17. 2009 Secreted Gaussia Luciferase as a Biomarker for Monitoring Tumor Progression and Treatment Response of Systemic Metastases PLoS ONE 4(12): e8316.
18. 2009 A mathematical model of murine metabolic regulation by leptin: energy balance and defense of a stable body weight Cell Metabolism 9: 52-63 (2009).
19. 2009 In Vivo Imaging of Extracellular Matrix Remodeling by Tumor-Associated Fibroblasts Nature Methods 6:143-145 (2009). PubMed link
20. 2009 Phase II Study of Imatinib Mesylate (Gleevec®) For Recurrent Meningiomas (North American Brain Tumor Consortium Study 01-08) Neuro-Oncology 11:853-60 (2009).
21. 2009 Micro-environmental Mechanical Stress Controls Tumor Spheroid Size and Morphology by Suppressing Proliferation and Inducing Apoptosis in Cancer Cells. PLoS ONE 4:e4632 PMID: 19247489 (2009).
22. 2009 Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knock out mice Journal of Cellular Physiology 219: 430-437 (2009).
23. 2009 Visualizing anti-tumor immune responses in vivo Disease Model and Mechanisms 2:107-10 (2009).
24. 2009 Mathematical Modeling of Herpes Simplex Virus Distribution in Solid Tumors: Implications for Cancer Gene Therapy Clinical Cancer Research 15: 2352- 2360 (2009).
25. 2009 Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis Cancer Research 69:2801-8 (2009).
26. 2009 The potential utility of anti-VEGF agents to normalize tumor vasculature and alleviate edema in brain and spinal cord tumor patients Nat Clin Pract Oncol. 6: 229-36 (2009).
27. 2009 Anti-vascular endothelial growth factor therapy for malignant glioma Current Neurol Neurosci Report 9:254-62 (2009).
28. 2009 Angiogenesis in Development, Disease and Regeneration Santin M, editor. Strategies in Regenerative Medicine: Integrating Biology with Materials Design. Chapter 6. Springer, New York (2009
29. 2009 Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: Role of local versus bone-marrow derived endothelial cells PLoS ONE 4: e4974 (2009).
30. 2009 PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment PLoS ONE_4(4): e5123 (2009).
31. 2009 Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo American J Pathology. 175: 294-302 (2009).
32. 2009 Angiogenesis as a therapeutic target in malignant gliomas. Oncologist 14:621-36 (2009
33. 2009 Feasibility of in vivo imaging of fluorescent proteins using lifetime contrast Optical Letters 34:2066-8 (2009).
34. 2009 Edema control by cediranib, a VEGF targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice Journal of Clinical Oncology 27: 2542-52 (2009).
35. 2009 Efficacy, safety and biomarkers of neoadjuvant bevacizumab, radiation therapy and 5-Fluorouracil in rectal cancer: A multidisciplinary phase II study Journal of Clinical Oncology 27: 3020-6 (2009).
36. 2009 Efficacy, safety and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: A phase II study Journal of Clinical Oncology 27: 3027-35 (2009
37. 2009 Biomarkers of benefit and resistance to antiangiogenic therapy Nature Reviews Clinical Oncology 6: 327-338 (2009)
38. 2009 A new target for tumor therapy New England Journal of Medicine 360: 2669-71 (2009).
39. 2009 A “Vascular Normalization Index as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Research 69: 5296-5300 (2009).
40. 2009 Vascular Normalization Index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients Cancer Research 69: 5296-5300 (2009)
41. 2009 Hearing improvement after bevacizumab in patients with neurofibromatosis 2 New England Journal of Medicine 361: 358-369 (2009).
42. 2009 Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging Nature Medicine 15: 1219- 23 (2009)
43. 2009 Development of Sunitinib in hepatocellular carcinoma: Rationale, early clinical experience and correlative studies The Cancer Journal, 15: 263-8 (2009).
44. 2008 A protocol for a lung neovascularization model in rodents Nature Protocols, 3:388-97 (2008).
45. 2008 Targeting Platelet-Derived Growth Factor Signaling in Carcinoma-Associated Fibroblasts Controls Cervical Cancer in Mouse Mode PLoS Medicine 5(1): e24 (2008); doi:10.1371/journal.pmed.0050024.
46. 2008 Perivascular nitric oxide gradients normalize tumor vasculature Nature Medicine 14: 255-257 (2008). PubMed link
47. 2008 Lessons from multidisciplinary translational trials on antiangiogenic therapy of cancer Nature Reviews Cancer 8:309-316 (2008). PubMed link
48. 2008 Histopathological findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice Comparative Medicine 58: 253-263 (2008).
49. 2008 Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors Cancer Research 68: 3795-802 (2008).
50. 2008 Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors, Cancer Research 68: 3795-802 (2008).
51. 2008 Judah Folkman Journal of Clinical Investigation 118: 823 (2008).
52. 2008 Photobleaching and recovery with nonlinear microscopy In: Handbook of Biomedical Nonlinear Optical Microscopy (Editors: B. R. Masters and P. T. C. So). Oxford University Press, New York, Chapter 26, pp. 673-688 (2008).
53. 2008 Applications of nonlinear intravital microscopy in tumor biology In: Handbook of Biomedical Nonlinear Optical Microscopy (Editors: B. R. Masters and P. T. C. So). Oxford University Press, New York, Chapter 29, pp. 735-756 (2008
54. 2008 Molecular Pathophysiology of Tumors In: Principles and Practice of Radiation Oncology, 5th Edition (Editors: E. C. Halperin, C. A. Parez, L. W. Brady), Lippincott, Williams & Wilkins, New York, Chapter 4, pp. 126-141 (2008).
55. 2008 Vascular and interstitial biology of tumors In: Clinical Oncology. 4th Edition, (Editors: Abeloff M, Armitage J, Niederhuber J, Kastan M, McKenna WG), Elsevier, Philadelphia. pp. 105- 24 (2008).
56. 2008 Normalization of tumor vasculature and microenvironment In: Angiogenesis: An Integrative Approach from Science to Medicine (Editors: W. D. Figg and J. Folkman), Springer, pp. 273-282 (2008).
57. 2008 Imaging angiogenesis and the microenvironment APMIS 116: 695-715 (2008).
58. 2008 Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and -3 kinase inhibitors cediranib and vandetanib Molecular Cancer Therapeutics 7: 2272-2279 (2008). PubMed
59. 2008 VEGFR3: A new target for anti-angiogenesis therapy? Developmental Cell 15:178-179 (2008).
60. 2008 Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas Current Opinion in Neurology 21:728-35 (2008).
61. 2008 Response criteria for glioma Nature Clinical Practice Oncology 5:634-44 (2008).
62. 2008 Taming vessels to treat cancer Scientific American, 298: 56-63 (2008). PubMed link
63. 2008 Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels Blood, 111: 1302-1305 (2008).
64. 2008 Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature Blood 111: 4551-4558 (2008).
65. 2008 A protocol for phenotypic detection and characterization of vascular cells in a lung neovascularization model in rodents R. Jones, D. Capen, K. S. Cohen, L. L. Munn, R. K. Jain, D. G. Duda
66. 2007 Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize Journal of Cellular Biochemistry, 101:937-949 (2007).
67. 2007 Tumor Angiogenesis and Blood Flow In: Imaging of Vertebrates (Editors: Tavitian B, Leroy-Willig A & Ntziachristos V). Wiley, London, pp 199-201 (2007).
68. 2007 Optical Microscopy in Small Animal Research In: Imaging of Vertebrates (Editors: Tavitian B, Leroy-Willig A & Ntziachristos V). Wiley, London, pp 183- 187 (2007).
69. 2007 Antiangiogenic agents for the treatment of glioblastoma Expert Opin Investig Drugs. 16:1895-1908 (2007).
70. 2007 aPlGF: A new kid on the antiangiogenic block Cell 131: 443-445 (2007).
71. 2007 MMP-1 and -8 improve the distribution and efficacy of an oncolytic virus Cancer Research, 67: 10664-10668 (2007).
72. 2007 Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells Neoplasia, 9: 1038-1045 (2007).
73. 2007 Tumor microvasculature and microenvironment: Targets for antiangiogenesis and normalization Microvascular Research, 74: 72-84.
74. 2007 Non-uniform plasma leakage affects local hematocrit and blood flow: Implications for inflammation and tumor perfusion Annals of Biomedical Engineering, 35:2121-29 (2007).
75. 2007 Small blood vessel engineering Methods in Molecular Medicine, 140:183-195 (2007).
76. 2007 Antiangiogenics: The potential role of integrating this novel treatment modality with chemoradiation for solid cancers J. Clinical Oncology, 225:4033-42 (2007).
77. 2007 Targeted therapy in rectal cancer Oncology, 21:1055-65 (2007).
78. 2007 Normalization of tumor vasculature and microenvironment In: Antiangiogenic Agents in Cancer Therapy. (Editors: Beverly Teicher and Lee Ellis), Humana Press, pp. 261-76 (2007).
79. 2007 Normalization of tumor vasculature and microenvironment by antiangiogenic therapy. In: Angiogenesis: Mechanisms and Cancer Therapy (Editors: Dieter Marmé and Norbert E. Fusenig), Springer-Verlag, Berlin, pp. 577-92 (2007).
80. 2007 Angiogenesis in Solid Tumors In: Antiangiogenic Cancer Therapy (Editors: James L. Abbruzzese, Darren W. Davis and Roy S. Herbst), CRC Press, Boca Raton, pp. 43-90 (2007).
81. 2007 Downregulation of Placenta Grwoth Factor by Promoter Hypermethylation in Human Lung and Colon Carcinoma Molecular Cancer Research 5:873-880 (2007).
82. 2007 Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: A potential strategy for plaque stabilization Nature Clinical Practice Cardiovascular Medicine, 4: 491-502 (2007). PubMed link
83. 2007 Angiogenesis in brain tumors Nature Reviews Neuroscience, 8:610-622 (2007). PubMed link
84. 2007 Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncology 8:444-8 (2007).
85. 2007 Data do not support benefits of anti-VEGFR3 therapy Cancer Research 67:5055 (2007).
86. 2007 The current progress, hurdles and future prospects in anti-VEGF targeted cancer therapy strategies Trends in Molecular Medicine 13: 222-230 (2007).
87. 2007 Surrogate biomarkers for anti-angiogenic therapy for advanced colorectal cancer Current Colorectal Cancer Reports 3:94-98 (2007).
88. 2007 A protocol for detection and enumeration of blood circulating endothelial cells and progenitor cells in human blood Nature Protocols 4: 805-810 (2007). PubMed link
89. 2007 Complete pathological response in T4 locally advanced rectal cancer after treatment with bevacizumab and standard radio-chemotherapy Nature Clinical Practice Oncology 4: 316-321 (2007)
90. 2007 Do the dietary supplements epigallocatechin gallate or vitamin E cause a radiomodifying response on tumors in vivo? J Soc Integr Oncol. 5:11-7 (2007).
91. 2007 Detection of circulating endothelial cells: CD146- based magnetic separation enrichment or flow cytometric assay? J Clin Oncol. 25: e3-e5 (2007).
92. 2007 Effects of vascular normalization on interstitial hypertension, peritumor edema and lymphatic metastasis: Insights from a mathematical model Cancer Research 67: 2729- 2735 (2007).
93. 2007 Human ES cell-derived endothelial cells form durable functional blood vessels in vivo Nature Biotechnology 25, 317 - 318 (2007). PubMed link
94. 2007 Robust 3-D modeling of vasculature imagery using superellipsoid IEEE Transactions on Medical Imaging, 26: 223-237 (2007).
95. 2007 AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients Cancer Cell, 11: 83-95 (2007). PubMed link (Chosen as a New Hot Paper in May 2008 by ScienceWatch for top 1% citation in the comparable field.)
96. 2006 Lessons from phase III trials on anti-VEGF therapy for cancer Nature Clinical Practice Oncology, 3: 24-40 (2006). PubMed
97. 2006 Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage PNAS, 103: 855-860 (2006).
98. 2006 Differential CD146 expression on circulating versus tissue endothelial cells in cancer patients: Implications for circulating endothelial cells as biomarker for antiangiogenic therapy Journal of Clinical Oncology, 24: 1449-1453 (2006).
99. 2006 Evidence for bone marrow-derived endothelial cells incorporation into perfused blood vessels in tumors Blood, 107: 2774-2776 (2006).
100. 2006 Combined Vascular Endothelial Growth Factor–Targeted Therapy and Radiotherapy for Colorectal Cancer: Theory and Clinical Practice Seminars in Oncology 33: S35-S40 (2006).
101. 2006 Seminal findings and an allergy to black flies. In: Reflections from the Frontiers, Explorations for the Future: Gordon Research Conferences, 1931-2006 (Editors: Arthur A. Daemmrich, Nancy Ryan Gray and Leah Shaper), Gordon Research Conferences and Chemical Heritage Foundation, Philadelphia, pp 70-71 (2006).
102. 2006 Role of nitric oxide in tumor progression Nature Review Cancer, 6: 521-534 (2006).
103. 2006 A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles Journal of Applied Physiology 101:1162-1169 (2006).
104. 2006 Platelet-derived growth factor receptor-in Gorham’s disease Nature Clinical Practice Oncology 3: 693-697 (2006).
105. 2006 Evolution of Oxygen and Glucose Concentration Profiles in a Tissue-Mimetic Culture System of Embryonic Stem Cells Annals of Biomedical Engineering, 34: 1247-1258 (2006).
106. 2006 Imaging steps of lymphatic metastasis reveals that VEGF-C increases metastasis by increasing delivery of cancer cells to lymph nodes: Therapeutic implications Cancer Research, 66: 8065-8075 (2006).
107. 2006 PlGF Overexpression Inhibits Tumor Growth, Angiogenesis and Metastasis by Depleting VEGF Homodimers in Orthotopic Mouse Models Cancer Research, 66: 3971-3977 (2006).
108. 2006 Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis Cancer Research, 66: 3360-3364 (2006).
109. 2006 Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic HSV vector Cancer Research, 66: 2509-2513 (2006).
110. 2005 Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, Angiopoietin-1, and matrix metallproteinases Cancer Cell 6: 553-562, 2004. PubMed link
111. 2005 Surrogate markers for antiangiogenic therapy and dose limiting toxicities for bevacizumab with radio-chemotherapy: Continued experience of a Phase I trial in rectal cancer patients Journal of Clinical Oncology, 23: 8136-8139 (2005).
112. 2005 A 2-D/3-D model-based method to quantify the complexity of microvasculature imaged by in vivo multiphoton microscopy Microvascular Research, 70: 165-178 (2005).
113. 2005 Molecular regulation of microlymphatic formation and function: Role of nitric oxide Trends in Cardiovascular Medicine, 15: 169-173 (2005).
114. 2005 A genetic Xenopus laevis tadpole model to study lymphangiogenesis Nature Medicine, 11: 998-1004 (2005).
115. 2005 Genetic evidence for a tumor suppressor role of HIF-2 Cancer Cell, 8:131-141 (2005).
116. 2005 NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissueengineered blood vessels Journal of Clinical Investigation, 115:1816-1827 (2005).
117. 2005 Green fluorescence protein (GFP)-expressing model derived from a spontaneous osteosarcoma in a VEGF-GFP expressing mouse Comparative Medicine, 55: 236-243 (2005).
118. 2005 Engineering vascularized tissue Nature Biotechnology, 23:821-823 (2005).
119. 2005 Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial markers Cancer Research, 65: 5740-5749 (2005).
120. 2005 Blocking PDGF-D/PDGFRb Signaling Inhibits Human Renal Cell Carcinoma Progression in an Orthotopic Mouse Model, Cancer Research, 65: 5711-5719
121. 2005 Lack of Telopeptides in Fibrillar Collagen I Promotes the Invasion of a Metastatic Breast Tumor Cell Line. Cancer Research, 65: 5674-5682 (2005).
122. 2005 Antiangiogenic therapy of cancer: Current and emerging concepts Oncology (Supplement), 19: 7-16 (2005). 46
123. 2005 Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo Nature Medicine 11, 678 - 682 (2005). PubMed link
124. 2005 Pleiotropy of tissue-specific growth factors: from neurons to vessels via the bone marrow Journal of Clinical Investigation, 115: 596-598 (2005).
125. 2005 A Practical Guide to in vivo Imaging of Tumors Cold Spring Harbor Press, Cold Spring Harbor, New York, Chapter 92, pages 695-700 (2005).
126. 2005 FRAP and Multiphoton FRAP Cold Spring Harbor, New York, Chapter 56, pages 429-438 (2005).
127. 2005 Microvascular Research: Biology and Pathology Academic Press (2005).
128. 2004 Correspondence: Recognition of tumor blood vessel normalization as a new antiangiogenic concept Nature Medicine, 10: 329-330 (2004).
129. 2004 The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis Nature, 428: 328-332 (2004). PubMed link
130. 2004 Tissue Engineering: Creation of long-lasting blood vessels Nature, 428: 138-139 (2004). PubMed link
131. 2004 Cancer cells compress intratumor vessels Nature, 427: 695 (2004). PubMed link
132. 2004 Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors Nature Medicine, 10: 203-207 (2004).
133. 2004 Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics Circulation Research, 95: 204-9 (2004).
134. 2004 Differential transplantibility of tumor-associated stromal cells Cancer Research, 64:5920-5924 (2004).
135. 2004 Intravital microscopy of normal and diseased tissues in the mouse In: Live Cell Imaging: A Laboratory Manual (Editors: R. D. Goldman and D. L. Spector). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, Chapter 24, pp. 435-466 (2004).
136. 2004 Vascular and Interstitial Biology of Tumors Elsevier, Philadelphia, PA, Chapter 9, pp. 153-172 (2004).
137. 2004 Zooming in and out with quantum dots Advanced Materials, 16: 23-24, 2004.
138. 2004 Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function Cancer Research, 64: 4400-4404 (2004)
139. 2004 Direct evidence that the VEGFspecific antibody bevacizumab has antivascular effects in human rectal cancer Nature Medicine, 10: 145-147 (2004). PubMed link
140. 2004 Vascular normalization by VEGFR2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors Cancer Research, 64: 3731-3736 (2004). PubMed link
141. 2004 Measurement of Macromolecular Diffusion Coefficients in Human Tumors Microvascular Research, 67: 231-236 (2004).
142. 2004 Differential Gene Expression in Metastasizing Cells Shed from Kidney Tumors Cancer Research, 64: 2469-2473 (2004).
143. 2004 Influence of the site of human gallbladder xenograft (Mz-ChA-1) on angiogenesis at the distant site Oncology Reports, 11: 803-807 (2004).
144. 2004 Role of eNOS in neovascularization: NO for endothelial progenitor cells TRENDS in Molecular Medicine, 10: 143-199 (2004).
145. 2003 Role of Bone Marrow-Derived Cells in Tumor Angiogenesis and Treatment Cancer Cell, 3: 515-516 (2003).
146. 2003 Molecular Pathophysiology of Tumors Williams & Wilkins, New York, Chapter 4, pp 163-179 (2003).
147. 2003 What brings pericytes to tumor vessels? Journal of Clinical Investigation 112: 1134-1136 (2003).
148. 2003 Irradiation Reduces Interstitial Fluid Transport and Increases the Collagen Content in Tumors Clinical Cancer Research 9: 5508-5513 (2003).
149. 2003 Solid Stress generated by spheroid growth estimated using a linear poroelasticity model Microvascular Research 66: 204-212 (2003).
150. 2003 Paracrine Regulation of Angiogenesis and Adipocyte Differentiation during In Vivo Adipogenesis Circulation Research 93: E88-E97 (2003). (Published on line on Oct 2, 2003).
151. 2003 Sparse initial entrapment of systemically injected salmonella typhimurium leads to heterogeneous accumulation within tumor necrosis Cancer Research 63: 5188-5193 (2003).
152. 2003 A Mathematical Model of the Contribution of Endothelial Progenitor Cells to Angiogenesis in Solid Tumors: Implications for Anti-Angiogenic Therapy Blood, 103: 2555-2561 (2003).
153. 2003 Automated Tracing and Change analysis of Angiogenic Vasculature from in vivo Multiphoton Confocal Image Time series Microvascular Research 66: 113-125 (2003).
154. 2003 Dynamic Imaging of Collagen and its Modulation in Tumors in vivo using Second Harmonic Generation Nature Medicine 9: 796- 801 (2003). PubMed link
155. 2003 Molecular Regulation of Vessel Maturation Nature Medicine, 9: 685-693 (2003). PubMed link (Times Cited: 421)
156. 2003 Lymphatics Make the Break Science, 299: 209-210 (2003).
157. 2003 Responses to Anti-Angiogenesis Treatment of Spontaneous Autochthonous Tumors and Their Isografts Cancer Research, 63: 747-751 (2003).
158. 2003 A Model for Temporal Heterogeneities of Tumor Blood Flow Microvascular Research, 65: 56-60 (2003).
159. 2003 Interstitial Transport in Solid Tumors In: Cancer Modeling and Simulation (Editor: L Preziosi), Chapman & Hall, Boca Raton, FL, Chapter 3, pp. 51-74 (2003)
160. 2003 Coupled Macromolecular Transport and Gel Mechanics: Poroviscoelastic Approach AIChE Journal, 49: 1580-1596 (2003)
161. 2003 Photodynamic Therapy for Cancer Nature Rev. Cancer 3: 380-387 (2003). PubMed link
162. 2002 Intratumoral Lymphatic Vessels: A Case of Mistaken Identity or Malfunction? JNCI 94: 417-421 (2002).
163. 2002 Dissecting Tumor Pathophysiology using Intravital Microscopy, Nature Reviews Cancer 2: 266-276 (2002). PubMed link
164. 2002 Herceptin Acts as an Anti-angiogenic Cocktail Nature 416: 279-280 (2002). PubMed link
165. 2002 Acid Production in Glycolysis-Impaired Tumors Provides New Insights into Tumor Metabolism Clinical Cancer Research 8: 1284-1291 (2002).
166. 2002 Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway. Mechanism of low pH induced VEGF. J Biol Chem., 277: 11368-11374 (2002).
167. 2002 Conventional and High-Speed Intravital Multiphoton Laser Scanning Microscopy of Microvasculature, Lymphatics, and Leukocyte-Endothelial Interactions Molecular Imaging 1: 9-15 (2002).
168. 2002 Blocking Tumor Angiogenesis: The Role of Bevacizumab (Avastin),” Supplement to Seminars in Oncology, 29 (2002).
169. 2002 Role of Host Microenvironment in Angiogenesis and Microvascular Functions in Human Breast Cancer Xenografts: Mammary Fat Pad vs. Cranial Tumors Clinical Cancer Research 8: 1008-1013 (2002). 43
170. 2002 Abnormalities In Pericytes on Blood Vessels and Endothelial Sprouts In Tumors American Journal of Pathology 160: 985- 1000 (2002).
171. 2002 Systemic Distribution And Tumor Localization Of Adoptively Transferred Lymphocytes In Mice: Comparison With Physiologically Based Pharmacokinetic Model Neoplasia, 4: 3-8 (2002).
172. 2002 Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics, Science, 296:1883-1886 (2002). PubMed link
173. 2002 Solid Stress Facilitates Spheroid Formation: Potential Involvement of Hyaluronan BJC 86: 947-953 (2002).
174. 2002 Diffusion and Convection in Collagen Gels: Implications for Transport in the Tumor Interstitium Biophysical Journal 83: 1650-1660 (2002).
175. 2002 Targeting Tumor Vasculature and Cancer Cells in Orthotopic Breast Tumor by Fractionated Photosensitizer Dosing Photodynamic Therapy Cancer Research 62: 4289-4294, (2002).
176. 2002 Antibody Directed Effector Cell Therapy of Tumors: Analysis and Optimization Using a Physiologically Based Pharmacokinetic Model Neoplasia 4: 449-463 (2002).
177. 2002 Prevention of Lymphatic Metastasis by Anti-Lymphangiogenic Therapy JNCI 94: 785-787 (2002).
178. 2002 Tumor Angiogenesis and Accessibility: Role of Vascular Endothelial Growth Factor Seminars in Oncology 29s: 3-9 (2002).
179. 2002 Angiogenesis and Lymphangiogenesis in Tumors: Insights from Intravital Microscopy Cold Spring Harbor Symposia on Quantitative Biology (The Cardiovascular System) 67: 239-248 (2002).
180. 2002 Comparison of IgG Diffusion and Extracellular Matrix Composition in Rhabdomyosarcomas Grown in Mice Versus In Vitro as Spheroids Reveals the Role of Host Stromal Cells British J Cancer, 86: 1639-1644 (2002).
181. 2002 Cationic Charge Determines the Distribution of Liposomes between the Vascular and Extravascular Compartments of Tumors Cancer Research, 62: 6831-6836 (2002).
182. 2002 Red Blood Cells Augment Leukocyte Rolling in a Virtual Blood Vessel, Biophysical Journal 83: 1834-1841 (2002)
183. 2002 Vascular Accumulation of a Novel Photosensitizer, MV6401, Causes Selective Thrombosis in Tumor Vessels following Photodynamic Therapy Cancer Research 62: 2151-2156
184. 2001 In vivo Measurement of Gene Expression, Angiogenesis and Physiological Function in Tumors Using Multiphoton Laser Scanning Microscopy Nature Medicine, 7:864-868 (2001). PubMed link
185. 2001 Can Engineered Bacteria Help Control Cancer?,” PNAS, 98: 14748-14750 (2001).
186. 2001 In Memoriam: Pietro M. Gullino (1919-2001),” Cancer Research, 61: 8930-8931 (2001).
187. 2001 Correspondence Regarding Fractals and Cancer Cancer Research 61: 8347- 8351, (2001).
188. 2001 Pancreas Microenvironment Promotes VEFG Expression and Tumor Growth: Novel Window Models for Pancreatic Tumor Angiogenesis And Microcirculation Lab Investigations 81: 1439-1451 (2001).
189. 2001 Vascular Morphogenesis and Remodeling in a Model of Tissue Repair: Blood Vessel Formation and Growth after Ovariectomy and Tumor Implantation Circulation Research 89: 732-739 (2001).
190. 2001 Vascular Morphogenesis and Remodeling in a Model of Tissue Repair: Blood Vessel Formation and Growth in the Ovarian Pedicle after Ovariectomy Circulation Research 89: 723-731 (2001).
191. 2001 Normalizing Tumor Vasculature with Anti-Angiogenic Therapy: A New Paradigm for Combination Therapy Nature Medicine, 7: 987-989 (2001). PubMed link
192. 2001 Hypoxia and Acidosis Independently Up-Regulate Vascular Endothelial Growth Factor Transcription in Brain Tumors In Vivo Cancer Research, 61:6020-6024 (2001).
193. 2001 A Potential Murine Model for Flap-Related Investigations Plastic and Reconstructive Surgery, 107:1504-1508 (2001).
194. 2001 Delivery of Molecular and Cellular Medicine to Solid Tumors Adv Drug Deliv Rev, 46: 149- 168 (2001).
195. 2001 Decorin Inhibits Endothelial Migration and Tube-Like Structure Formation: Role of Thrombospondin-1 Microvascular Research, 62: 26-42 (2001).
196. 2001 Clearing the Smoke on Nicotine and Angiogenesis Nature Medicine, 7:775-777 (2001).
197. 2001 Modulation of A-NK Cell Rigidity: In Vitro Characterization and In Vivo Implications for Cell Delivery Biorheology, 38:151-159 (2001).
198. 2001 Kinetics of Placenta Growth Factor/Vascular Endothelial Growth Factor Synergy in Endothelial Hydraulic Conductivity and Proliferation Microvascular Research, 61: 203-210 (2001).
199. 2001 Vascular endothelial Growth Factor (VEGF)-C Differentially Affects Tumor Vascular Function and Leukocyte Recruitment: Role of VEGF-Receptor 2 and Host VEGF-A Cancer Research, 61: 2404- 2408 (2001).
200. 2001 VEGF Receptor-2 Blocking Antibody Potentiates Radiation-Induced Long Term Control of Human Tumor Xenografts Cancer Research, 61: 39-44 (2001).
201. 2001 A Lateral View Flow System for Studies of Cell Adhesion and Deformation under Flow Conditions Biotechniques, 30:388-394 (2001).
202. 2001 Role of Tumor-Host Interactions in Interstitial Diffusion of Macromolecules: Cranial vs. subcutaneous tumors PNAS, 98: 4628-4633 (2001). PubMed link
203. 2001 Predominant Role of Endothelial Nitric Oxide Synthase in VEGF-induced Angiogenesis and Vascular Permeability PNAS, 98: 2604-2609 (2001). PubMed link
204. 2001 Transparent Window Models and Intravital Microscopy: Imaging Gene Expression, Physiological Function and Drug Delivery in Tumors In: Tumor Models in Cancer Research, B. Teicher, Ed., Humana Press, Inc., Totowa, NJ, Chapter 34: 647-671 (2001).
205. 2001 Delivery of Molecular Medicine to Solid Tumors: Lessons from In Vivo Imaging of Gene Expression and Function J Controlled Release, 74: 7-25 (2001).
206. 2000 Angiogenesis in Cancer and Other Diseases Nature, 407: 249-257 (2000). PubMed link
207. 2000 Anti-Vascular Endothelial Growth Factor Treatment Augments Tumor Radiation Response Under Normoxic or Hypoxic Conditions Cancer Research, 60: 5565-5570 (2000).
208. 2000 Vascular Endothelial Growth Factor Modulation by Targeting HIF-1→HRE→VEGF Cascade Differentially Regulates Vascular Response and Growth Rate in Tumors Cancer Research, 60: 6248-6252 (2000).
209. 2000 Mosaic Blood Vessels in Tumors: Frequency of Cancer Cells in Contact with Flowing Blood, PNAS, 97: 14608- 14613 (2000). PubMed link
210. 2000 Local Imbalance of Angiogenic and Anti-Angiogenic Regulators: A Potential Mechanism of Focal Necrosis and Dormancy in Primary Tumors Cancer Research, 60: 1442-1448 (2000).
211. 2000 Delivery of Biologic Molecules and Cells to Tumors In: Biologic Therapy of Cancer: Principles and Practice, S. Rosenberg, Ed., Lippincott, Williams and Watkins, Philadelphia, pp. 865-874 (2000).
212. 2000 Erythrocytes Enhance Lymphocyte Rolling and Arrest in Vivo, Microvascular Research, 59: 316-322 (2000).
213. 2000 Effect of Vascular Endothelial Growth Factor on Cultured Endothelial Cell Monolayer Transport Properties Microvascular Research, 59: 265-277 (2000).
214. 2000 Leaky Vessels? Call Ang1! Nature Medicine, 6:131-32 (2000).
215. 2000 Vascular Permeability in a Human Tumor Xenograft: Molecular Charge Dependence British Journal of Cancer, 82: 1513-1518 (2000).
216. 2000 Openings Between Defective Endothelial Cells Contribute to Tumor Vessel Leakiness American Journal of Pathology, 156: 1363-1380 (2000).
217. 2000 Irradiation of a Primary Tumor, Unlike Surgical Removal, Enhances Angiogenesis Suppression at a Distal Site: Potential Role of Host-Tumor Interaction Cancer Research, 60: 2128-2131 (2000).
218. 2000 Role of Extracellular Matrix Assembly in Interstitial Transport in Solid Tumors. Cancer Research, 60: 2497-2503 (2000).
219. 2000 Formation of Endothelial Cell Networks Nature, 405: 139-141 (2000). PubMed link
220. 2000 Fractals and Cancer Cancer Research, 60: 3683-88 (2000).
221. 2000 Differential Dynamics of CD4+ and CD8+ T Lymphocyte Proliferation and Activation in acute Simian Immunodeficiency Virus Infection Journal of Virology, 74: 8413-8424 (2000).
222. 2000 Oncotic Pressure in Solid Tumors is Elevated Cancer Research, 60: 4251-4255 (2000).
223. 2000 Absence of Functional Lymphatics within a Murine Sarcoma: a Molecular and Functional Evaluation Cancer Research, 60: 4324-4327 (2000).
224. 2000 Tumor Oxygenation during Vascular Endothelial Growth Factor 2 Blockade, Hormone Ablation, and Chemotherapy Cancer Research , 60: 4556-4560 (2000).
225. 2000 Investigation of Thin Aqueous Films on Silica Using a Modified Interferometric Technique Journal of Colloid and Interface Science, 225: 243- 246 (2000).
226. 1999 Diffusion of Macromolecules in Agarose Gels: Comparison of Linear and Globular Configurations Biophysical Journal, 77:542-552 (1999).
227. 1999 Cells Shed from Tumors Show Reduced Clonogenicity, Resistance to Apoptosis, and in vivo Tumorigenicity British Journal of Cancer, 81:756-759 (1999).
228. 1999 Changes in Vascularization of Human Breast Cancer Xenografts Responding to Estrogen Withdrawal and Tamoxifen Therapy Neoplasia, 1:518-525 (1999).
229. 1999 Mechanics of Interstitial-Lymphatic Fluid Transport: Theoretical Foundation and Experimental Validation Journal of Biomechanics, 32: 1297-1303 (1999)
230. 1999 Transport of Molecules, Particles, and Cells in Solid Tumors Annual Reviews of Biomedical Engineering, 1:241-263 (1999).
231. 1999 Tumor-host Interactions in the Gallbladder Suppress Distal Angiogenesis and Tumor Growth: Role of TGF Nature Medicine, 5:1203-1208 (1999). PubMed link
232. 1999 Angiogenesis in the huPBL-SCID Model of Human Transplant Rejection Transplantation, 67:1626-1631 (1999).
233. 1999 Thinning and Rupture of Aqueous Surfactant Films on Silic Langmuir, 15: 7658-7661 (1999).
234. 1999 Water Channel (Aquaporin 1) Expression and Distribution in Mammary Carcinomas and Glioblastomas Microvascular Research, 58: 89-98 (1999).
235. 1999 Cellular Membrane Permeability of Anthracyclines Does Not Effect Their Delivery in a Tissue Isolated Tumor Cancer Research, 59:4458-4463 (1999).
236. 1999 Augmentation of Transvascular Transport of Macromolecules and Nanoparticles in Tumors Using Vascular Endothelial Growth Factor,” Cancer Research, 59:4129-4135 (1999).
237. 1999 Understanding Barriers to Drug Delivery: High Resolution In Vivo Imaging is Key Clinical Cancer Research, 5:1605-1606 (1999).
238. 1999 Taxane-Induced Apoptosis Decompresses Blood Vessels and Lowers Interstitial Fluid Pressure in Solid Tumors: Clinical Implications Cancer Research, 59:3776-3782 (1999).
239. 1999 Effect of Anti-VEGF Antibody on Tumor Microvessel Permeability Microvascular Research, 57:357-362 (1999).
240. 1999 Return of Lymphatic Function Following Flap Transfer for Acute Lymphedema Annals of Surgery, 229:421-427 (1999).
241. 1999 Creatine and Cyclocreatine Treatment of Human Colon Adenocarcinoma Xenografts:31P and 1H Magnetic Resonance Spectroscopic Studies, British Journal of Cancer, 79:278-285 (1999).
242. 1999 Creatine and Cyclocreatine Treatment of Human Colon Adenocarcinoma Xenografts:31P and 1H Magnetic Resonance Spectroscopic Studies British Journal of Cancer, 79:278-285 (1999).
243. 1998 Enhancement of Fluid Filtration Across Tumor Vessels: Implication for Delivery of Macromolecules PNAS, 96:3137-3142 (1999). PubMed link
244. 1998 Tumor Pretargeting for Radioimmunodetection and Radioimmunotherapy: Evaluation Using a Physiologically-Based Pharmacokinetic Model Journal of Nuclear Medicine, 39:65-76 (1998).
245. 1998 Regulation of Transport Pathways in Tumor Vessels: Role of Tumor Type and Microenvironment PNAS, 95:4607- 4612 (1998). PubMed link
246. 1998 Dynamic T1-weighted Magnetic Resonance Imaging and Positron Emission Tomography in Patients with Lung Cancer: Correlating Vascular Physiology with Glucose Metabolism Clinical Cancer Research, 4:949-955 (1998).
247. 1998 Increased Rates of CD4+ and CD8+ T Lymphocyte Turnover in Simian Immunodeficiency Virus-infected Macaques PNAS, 95:6388-6393 (1998). PubMed link
248. 1998 Intracellular Magnetic Labeling of Lymphocytes for in vivo Trafficking Studies Biotechniques, 24:642-651 (1998).
249. 1998 Increased Microvascular Density and Enhanced Leukocyte Rolling and Adhesion in the Skin of VEGF Transgenic Mice Journal of Investigative Dermatology, 3:1-6 (1998).
250. 1998 Role of HIF-1in Hypoxia-mediated Apoptosis, Cell Proliferation and Tumor Angiogenesis Nature, 394:485-490 (1998). PubMed link
251. 1998 Tumor Induction of VEGF Promoter Activity in Stromal Cells Cell, 94:715-725 (1998). PubMed link
252. 1998 Endothelial Cell Death, Angiogenesis, and Microvascular Function Following Castration in an Androgendependent Tumor: Role of VEGF PNAS, 95:10820-10825 (1998). PubMed link
253. 1998 Mice Lacking E-selectin Show Normal Rolling But Reduced Arrest of Leukocytes on Cytokine-Activated Microvascular Endothelium Microcirculation, 5:153-171 (1998).
254. 1998 Intratumoral Infusion of Fluid: Estimation of Hydraulic Conductivity and Implications for the Delivery of Therapeutic Agents British Journal of Cancer, 78:1442-1448 (1998).
255. 1998 Primary Tumor Size-Dependent Inhibition of Angiogenesis at a Secondary Site: An Intravital Microscopic Study in Mice Cancer Research, 58:5866- 5869 (1998).
256. 1998 The Next Frontier of Molecular Medicine: Delivery of Therapeutics Nature Medicine, 4:655-657 (1998). PubMed link
257. 1998 Integrative Pathophysiology of Solid Tumors: Role in Detection and Treatment The Cancer Journal from Scientific American, 4:48-57 (1998).
258. 1998 Delivery of Molecular and Cellular Medicine to Solid Tumors Journal of Controlled Release, 53:49-67 (1998).
259. 1998 Role of Nitric Oxide in Angiogenesis and Microcirculation in Tumors Cancer and Metastasis Reviews, 17:77-89 (1998).
260. 1998 Cancer, Angiogenesis and Fractals Nature Medicine, 4:984 (1998).
261. 1998 Tumor Microcirculation: Role in Delivery of Molecular and Cellular Medicine In: The Biology of Tumors, Proceedings of the Ninth Annual Pezcoller Symposium on the Biology of Tumors, Rovereto, Italy, June 4-7, 1997, 319-345 (1998).
262. 1998 In Vitro and In Vivo Quantification of Adhesion Between Leukocytes and Vascular Endothelium In: Methods in Molecular Medicine - Methods in Tissue Engineering, J.R. Morgan and M.L. Yarmush, Eds., Humana Press, Totowa, pp 553-575 (1998).
263. 1998 Delivery of Monoclonal Antibodies to the Tumor Cell “ In: Monoclonal Antibody-Based Therapy of Cancer, M.L. Grossbard, Ed., Marcel Dekker, Inc., New York, pp 23-52 (1998).
264. 1997 Interstitial pH and pO2 Gradients in Solid Tumors In Vivo: High-Resolution Measurements Reveal a Lack of Correlation Nature Medicine, 3:177-182 (1997). PubMed link
265. 1997 Microcirculation and Transport Phenomena in Tumours In: Connective Tissue Biology: Integration and Reductionism. Eds. R.K. Reed and K. Rubin, Portland Press Ltd, London, 71:269-293
266. 1997 Tumor Microcirculation: Role in Drug and Nutrient Delivery In: Advances in Blood Substitutes, Eds, R.M. Winslow, K. D. Vandegriff, and M. Intaglietta, Birkhäuser, Boston, pp 46-70 (1997).
267. 1997 Delivery of Molecular Medicine to Solid Tumors In: Microcirculation Annual 1997, M. Tsuchiya, M. Asano and N. Sato, Eds, Nihon-Igakukan, Tokyo, 13:1-5 (1997).
268. 1997 p02 Measurements in Murine Tumors Using Eppendorf "Histograph": Calibration, Reproducibility and Comparison with Diamond-General Device International Journal of Oncology, 9:955-962 (1997).
269. 1997 Fractal Characteristics of Tumor Vascular Architecture During Tumor Growth and Regression Microcirculation, 4:395-402 (1997).
270. 1997 Interlaboratory Variation in Oxygen Tension Measurement by Eppendorf “Histograph” and Comparison With Hypoxic Marker Journal of Surgical Oncology, 66:30-38 (1997).
271. 1997 Effects of Needle Insertion in Tumors on Interstitial Fluid Pressure Microvascular Research, 54:174-177 (1997).
272. 1997 Quantitative Angiogenesis Assays: Progress and Problems, Nature Medicine, 3:1203-1208 (1997). PubMed link
273. 1997 Delivery of Molecular and Cellular Medicine to Solid Tumors Advanced Drug Delivery Reviews, 26:71-90 (1997).
274. 1997 Vascular and Interstitial Physiology of Tumours: Role in Cancer Detection and Treatment In: Tumor Angiogenesis, R. Bicknell, C. Lewis and N. Ferrara, Eds, Oxford University Press, Oxford, pp 45-59 (1997).
275. 1997 Effect of Host Microenvironment on the Microcirculation of Human Colon Adenocarcinoma American Journal of Pathology, 150:679-688 (1997).
276. 1997 Solid Stress Inhibits the Growth of Multicellular Tumor Spheroids Nature Biotechnology, 15:778-783 (1997). PubMed link
277. 1997 Early Events of Metastasis in the Microcirculation Involve Changes in Gene Expression of Cancer Cells American Journal of Pathology, 150:2099-2112 (1997).
278. 1997 Effect of bFGF on Angiogenesis and Growth of Isografted Bone: Quantitative in vitro -in vivo Analysis in Mice International Journal of Microcirculation, 17:1-9
279. 1997 Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice Science, 276:1423-1425 (1997). PubMed link
280. 1997 Direct in vivo Measurement of Targeted Binding in a Human Tumor Xenograft, PNAS, 94:1785-1790 (1997). PubMed Link
281. 1997 Potential and Limitations of Radioimmunodetection and Radioimmunotherapy with Monoclonal Antibodies: Evaluation Using a Physiologically-Based Pharmacokinetic Model Journal of Nuclear Medicine, 38:731-741 (1997).
282. 1997 Adhesion of Activated Natural Killer Cells to TNF- Treated Endothelium Under Physiological Flow Conditions Natural Immunity, 15:154-163 (1997).
283. 1997 Macro- and Microscopic Fluid Transport in Living Tissues: Application to Solid Tumors AIChE Journal, 43:818-834 (1997).
284. 1997 The Problem of Chronic Rejection: Influence of Leukocyte-Endothelial Interactions Kidney International, 51:S-22-S-27 (1997).
285. 1997 Interstitial Fluid Pressure in Intracranial Tumors in Patients and in Rodents British Journal of Cancer, 75:829-836 (1997).
286. 1997 Geometric Resistance and Microvascular Network Architecture of Human Colorectal Carcinoma Microcirculation, 4:25-33 (1997).
287. 1997 1996 Landis Award Lecture: Delivery of Molecular and Cellular Medicine to Solid Tumors Microcirculation, 4:1-23 (1997).
288. 1997 Role of Nitric Oxide in Tumor Microcirculation: Blood Flow, Vascular Permeability, and Leukocyte-endothelial Interactions American Journal of Pathology, 150:713-725 (1997).
289. 1997 Effect of Tumor Necrosis Factor-on Vascular Resistance, Nitric Oxide Production, Glucose and Oxygen Consumption in Perfused, Tissue-Isolated Human Melanoma Xenografts Clinical Cancer Research, 3:319-324 (1997).
290. 1996 1995 Whitaker Lecture: Delivery of Molecules, Particles and Cells to Solid Tumors Annals of Biomedical Engineering, 24:457-473 (1996). PubMed link
291. 1996 Quantitation and Physiological Characterization of bFGF and VEGF/VPF Induced Vessels in Mice: Effect of Microenvironment on Angiogenesis American Journal of Pathology, 149:59-71 (1996).
292. 1996 Solid Tumor Barriers to Anticancer Drugs Cope, 12:22-23 (1996).
293. 1996 Role of Erythrocytes in Leukocyte-endothelial Interactions: Mathematical Model and Experimental Validation Biophysical Journal, 71:466-478 (1996).
294. 1996 Oxygenation in Tumors by Modified Hemoglobins Journal of Surgical Oncology, 62:109-114 (1996).
295. 1996 Effect of Transvascular Fluid Exchange on Arterio-Venous Pressure Relationship: Implication for Temporal and Spatial Heterogeneities in Tumor Blood Flow Microvascular Research, 52:27-46 (1996).
296. 1996 Reduction of Interstitial Fluid Pressure After TNF- Treatment of Human Melanoma Xenografts British Journal of Cancer, 74:533-536 (1996).
297. 1996 Physiologically Based Kinetic Model of Effector Cell Biodistribution in Mammals: Implications for Adoptive Immunotherapy Cancer Research, 56:3771-3781
298. 1996 Tumor Angiogenesis and Interstitial Hypertension Cancer Research, 56:4264-4266 (1996).
299. 1996 During Angiogenesis, Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Regulate Natural Killer Cell Adhesion to Tumor Endothelium Nature Medicine, 2:992-997 (1996). PubMed
300. 1996 Compatibility and the Genesis of Residual Stress by Volumetric Growth Journal of Mathematical Biology, 34:889-914 (1996).
301. 1996 Fluorescence Ratio Imaging and Optical Sectioning: Effect of Glucose on Spatial and Temporal Gradients British Journal of Cancer, 74:1206-1215 (1996).
302. 1996 Lateral Diffusion of Small Compounds in Human Stratum Corneum and Model Lipid Bilayer Systems Biophysical Journal, 71:2656-2668 (1996).
303. 1996 Time-dependent Vascular Regression and Permeability Changes in Established Human Tumor Xenografts Induced By an Anti- VEGF/VPF Antibody PNAS, 93:14765-14770 (1996). PubMed link
304. 1996 Perfusion of Single Tumor Microvessels: Application to Vascular Permeability Measurement Microcirculation, 3:349-357 (1996).
305. 1996 Hindered Diffusion in Agarose Gels: Test of Effective Medium Model Biophysical Journal, 70:1017-1026 (1996).
306. 1996 Intussusceptive Microvascular Growth in Solid Tumors: A Novel Mechanism of Tumor Angiogenesis, Microvascular Research, 51:260-272 (1996).
307. 1996 Pharmacokinetic Analysis of the Microscopic Distribution of Enzymeconjugated Antibodies and Prodrugs: Comparison with Experimental Data British Journal of Cancer, 73:447-456 (1996).
308. 1996 Delivery of Molecular Medicine to Solid Tumors Science, 271:1079-1080 (1996). PubMed
309. 1996 Intratumor Pharmacokinetics, Flow Resistance, and Metabolism During Gemcitabine Infusion in Ex Vivo Perfused Human Small Cell Lung Cancer Clinical Cancer Research, 2:359-367 (1996).
310. 1996 Transport in Lymphatic Capillaries: II. Microscopic Velocity Measurement with Fluorescence Recovery After Photobleaching American Journal of Physiology, 270:H330-H337 (1996).
311. 1996 Transport in Lymphatic Capillaries: I. Macroscopic Measurements Using Residence Time Distribution Theory American Journal of Physiology, 270:H324-H329 (1996).
312. 1996 Heating or Freezing Bone: Effects on Angiogenesis Induction and Growth Potential in Mice Acta Orthop Scand., 67:383-388 (1996).
313. 1996 Drug Delivery: Barriers to Drug Transport and the Design of Novel Therapeutic Agents Molecular Medicine Today, 1:4 (1996).
314. 1996 Role of Tumor Vascular Architecture in Nutrient and Drug Delivery: An Invasion Percolation Model Microvascular Research, 51:327-346 (1996).
315. 1996 Leukocyte-Endothelial Adhesion and Angiogenesis in Tumors Cancer and Metastasis Reviews, 15:195-204 (1996).
316. 1995 Pharmacologic Modification of Tumor Blood Flow and Interstitial Fluid Pressure in a Human Tumor Xenograft: Network Analysis and Mechanistic Interpretation Microvascular Research, 50:429-443 (1995
317. 1995 Selectin and Integrin Mediated T Lymphocyte Rolling and Arrest on TNF-activated Endothelium is Augmented by Erythrocytes Biophysical Journal, 69:2131-2138 (1995).
318. 1995 Rolling in P-Selectin Deficient Mice is Reduced but Not Eliminated in the Dorsal Skin Blood, 86:3487-3492 (1995).
319. 1995 TNFa-Induced Leukocyte- Adhesion in Normal and Tumor Vessels: Effect of Tumor Type, Transplantation Site and Host Cancer Research, 55:4824-4829 (1995).
320. 1995 Biodistribution of Monoclonal Antibodies: Scale-up from Mouse to Human Using a Physiologically Based Pharmacokinetic Model Cancer Research, 55:4611-4622 (1995).
321. 1995 Scale-Invariant Behavior and Vascular Network Formation in Normal and Tumor Tissue Physical Review Letters, 75:2428-2431 (1995).
322. 1995 Kinetics of Adhesion Molecule Expression and Spatial Organization Using Targeted Sampling Fluoremetry BioTechniques, 19:622-631 (1995).
323. 1995 Diffusion and Partitioning of Proteins in Charged Agarose Gels Biophysical Journal, 68:1561-1568 (1995).
324. 1995 Interaction of Activated Natural Killer Cells with Normal and Tumor Vessels in Cranial Windows in Mice Microvascular Research, 50, 35-44 (1995).
325. 1995 Vascular Permeability in a Human Tumor Xenograft: Molecular Size-dependence and Cut-off Size Cancer Research, 55:3752-3756 (1995).
326. 1995 Leukocyte-rolling Increases with Age Blood, 86:4707-4708 (1995).
327. 1995 Lack of General Correlation between Interstitial Fluid Pressure and Oxygen Partial Pressure in Solid Tumors Microvascular Research, 50:175-182 (1995).
328. 1995 Time Dependent Behavior of Interstitial Pressure in Solid Tumors: Implications for Drug Delivery Cancer Research, 55:5451-5458 (1995).
329. 1995 Quantitative Analysis of Angiogenesis and Growth of Bone: Consequences of Indomethacin Exposure in a Combined In Vitro - In Vivo Approach Res. Exp. Medicine, 195:275-288 (1995).
330. 1994 Flow Velocity in the Superficial Lymphatic Network of the Mouse Tail American Journal of Physiology, 267:H1507-H1513 (1994).
331. 1994 Barriers to Drug Delivery in Solid Tumors Scientific American, 271:58-65 (1994). PubMed link
332. 1994 Tumor Microcirculation: Role in Cancer Diagnosis and Treatment In: Progress in Microcirculation Research, H. Niimi, et al, Eds., pp 29-36, Pergamon Press, Tarrytown (1994).
333. 1994 Transport Phenomena in Tumors Advances in Chemical Engineering, 20:129-200 (1994).
334. 1994 A Method for Labeling Cells for Positron Emission Tomography (PET) Studies Journal of Immunological Methods, 175:79-87 (1994).
335. 1994 Reduction of Rigidity in Human Activated Natural Killer Cells by Thioglycollate Treatment Journal of Immunological Methods, 175:69-77 (1994).
336. 1994 Analysis of Cell Flux in the Parallel Plate Flow Chamber: Implications for Cell Capture Studies Biophysical Journal, 67:889-895 (1994).
337. 1994 Spatial Heterogeneity in Tumor Perfusion Measured with Functional Computed Tomography at 0.05ml Resolution Cancer Research, 54:6032-6036 (1994).
338. 1994 Noninvasive Measurement of Interstitial pH Profiles in Normal and Neoplastic Tissue Using Fluorescence Ratio Imaging Microscopy Cancer Research, 54:5670-5674 (1994).
339. 1994 Vascular Permeability and Microcirculation of Gliomas and Mammary Carcinomas Transplanted in Rat and Mouse Cranial Windows Cancer Research, 54:4564-4568 (1994).
340. 1994 Tissue-Isolated Human Tumor Xenografts in Athymic Nude Mice Microvascular Research, 48:389-402 (1994).
341. 1994 Effect of Hemodilution and Resuscitation on Tumor Interstitial Fluid Pressure, Blood Flow and Oxygenation Microvascular Research, 48:1-12 (1994).
342. 1994 Angiogenesis and Growth of Isografted Bone: Quantitative In Vivo Assay in Nude Mice Laboratory Investigations, 71:300-307 (1994).
343. 1994 Microvascular Permeability and Interstitial Penetration of Sterically Stabilized (Stealth) Liposomes in a Human Tumor Xenograft Cancer Research, 54:3352-3356 (1994).
344. 1994 Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline British Journal of Cancer, 69:492-496 (1994).
345. 1994 Residence Time Distributions of Various Tracers in Tumors: Implications for Drug Delivery and Blood Flow Measurement Journal of the National Cancer Institute, 86:293-299 (1994).
346. 1994 Physiologically Based Pharmacokinetic Model for Specific and Nonspecific Monoclonal Antibodies and Fragments in Human Tumor Xenograft in Nude Mice Cancer Research, 54:1517-1528 (1994).
347. 1994 Photodynamic Therapy-induced Alterations in Interstitial Fluid Pressure, Volume and Water Content of an Amelanotic Melanoma in the Hamster,” British Journal of Cancer, 69:101-103 (1994).
348. 1993 Non-invasive Measurement of Microvascular and Interstitial p02 Profiles in a Human Tumor in SCID Mice PNAS, 91:2081-2085 (1994). PubMed link
349. 1993 Imaging of Activated Natural Killer Cells in Mice by Positron Emission Tomography: Preferential Uptake in Tumors Cancer Research, 53:5867-5871 (1993).
350. 1993 Delivery of Effector Cells to Tumors In: '93 Recent Advances in Cancer Research, J.G. Park, Ed., pp. 202-217, Seoul National University, Seoul, (1993).
351. 1993 Physiological Resistance to the Treatment of Solid Tumors ,” In: Drug Resistance in Oncology, B. Teicher, Ed., Chapter 4, pp 87-105, M. Dekker, New York (1993).
352. 1993 Dexamethasone Reduces the Interstitial Fluid Pressure in a Human Colon Adenocarcinoma Xenograft Cancer Research, 53:4764-4766 (1993).
353. 1993 Fluorescence Photobleaching with Spatial Fourier Analysis: Measurement of Diffusion in Light-Scattering Media Biophysical Journal, 65:2428-2436 (1993).
354. 1993 Fluorescence Ratio Imaging of pH Gradients: Calibration and Application in Normal and Tumor Tissues Microvascular Research, 46, 216-230 (1993).
355. 1993 Effect of Angiotensin II Induced Hypertension on Tumor Blood Flow and Interstitial Fluid Pressure Cancer Research, 53:2466-2468 (1993).
356. 1993 Role of Oxygen versus Glucose in Energy Metabolism in a Mammary Carcinoma Perfused Ex Vivo: Direct Measurement by 31P NMR PNAS, 90:2646-2650 (1993).
357. 1993 Microvascular Permeability of Albumin, Vascular Surface Area and Vascular Volume Measured in Human Adenocarcinoma LS174T Using Dorsal Chamber in SCID Mice Microvascular Research, 45:269-289 (1993).
358. 1993 Extravasation and Interstitial Transport in Tumors In: Biological Barriers to Protein Delivery, K.L. Audus and T.J. Raub, Eds., Chapter 15, pp 441-465, Plenum Press, New York (1993).
359. 1992 Interstitial Fluid Pressure in Solid Tumors Following Hyperthermia: Possible Correlation with Therapeutic Response Cancer Research, 52:487-490 (1992).
360. 1992 Pharmacokinetic Analysis of the Perivascular Distribution of Bifunctional Antibodies and Haptens Cancer Research, 52:5838-5844 (1992).
361. 1992 2H NMR Imaging of Tumor Blood Flow: Spatial and Temporal Heterogeneity in a Tissue-isolated Mammary Adenocarcinoma Cancer Research, 52:6010- 6019 (1992). 33
362. 1992 Interstitial Hypertension in Human Breast and Colorectal Tumors Cancer Research, 52:6371-6374 (1992).
363. 1992 Kinetics of Interleukin - 2 Induced Changes in Rigidity of Human Natural Killer Cells Cell Biophysics, 20:161-176 (1992).
364. 1992 Angiogenesis, Microvascular Architecture, Microhemodynamics and Interstitial Fluid Pressure During Early Growth of Human Adenocarcinoma LS174T in SCID Mice Cancer Research, 52:6553-6560 (1992).
365. 1992 In Vitro Measurement and Screening of Monoclonal Antibody Affinity Using Fluorescence Photobleaching J. Immunol. Methods, 155:1-17 (1992).
366. 1992 Microvascular Pressure Is the Principal Driving Force for Interstitial Hypertension in Solid Tumors: Implications for Vascular Collapse Cancer Research, 52:5110-5114 (1992).
367. 1992 Nicotinamide Can Lower Tumor Interstitial Fluid Pressure: Mechanistic and Therapeutic Implications Cancer Research, 52:3237-3240 (1992).
368. 1992 Interstitial Hypertension in Head and Neck Tumors in Patients: Correlation with Tumor Size Cancer Research, 52:1993-1995 (1992).
369. 1992 Effect of Bivalent Interaction Upon Apparent Antibody Affinity: Experimental Confirmation of Theory Using Fluorescence Photobleaching and Implications for Antibody Binding Assays Cancer Research, 52:4157-4167 (1992).
370. 1991 Parameters Governing Tumor Blood Flow In: Tumor Blood Supply and Metabolic Microenvironment: Characterization and Therapeutic Implications, P. Vaupel and R.K. Jain, Eds., Fischer Publications, Stuttgart (1991).
371. 1991 Tumor Blood Supply and Metabolic Microenvironment: Characterization and Therapeutic Implications Gustav Fischer Publications, Stuttgart
372. 1991 Microvascular architecture in a mammary carcinoma: branching patterns and dimensions Cancer Research, 51:265-273 (1991).
373. 1991 Measurement of capillary filtration coefficient in a solid tumor Cancer Research, 51:1352-1355 (1991).
374. 1991 IL-2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular-leaksyndrome Cancer Research, 51:1561-1563 (1991).
375. 1991 Effect of RBC Rigidity on Tumor Blood Flow: Increase in Viscous Resistance During Hyperglycemia Cancer Research, 51:2727-2730 (1991).
376. 1991 Pharmacokinetic Analysis of Two-step Approaches Using Bifunctional and Enzyme-conjugated Antibodies Cancer Research, 51:3119-3130 (1991).
377. 1991 Effect of I.V. Versus I.P. Glucose Injection on Systemic Hemodynamics and Blood Flow Rate in Normal and Tumor Tissues in Rats Cancer Research, 51:3612- 3616 (1991).
378. 1991 Interstitial Hypertension in Superficial Metastatic Melanomas in Humans Cancer Research, 51:6691-6694 (1991). 32
379. 1991 Interstitial Hypertension in Carcinoma of Uterine Cervix in Patients: Possible Correlation with Tumor Oxygenation and Radiation Response Cancer Research, 51:6695-6698 (1991).
380. 1991 Preferential Localization of Human A-LAK Cells in Tumor Microcirculation: A Novel Mechanism of Adoptive Immunotherapy Journal of National Cancer Institute, 83:433-437 (1991).
381. 1991 Transport of Fluid and Macromolecules in Tumors. III. Role of Binding and Metabolism Microvascular Research, 41:5-23 (1991).
382. 1991 Transport of Fluid and Macromolecules in Tumors. IV. A Microscopic Model of the Perivascular Distribution Microvascular Research, 41:252-272 (1991).
383. 1991 Measurement of Mass Transport and Reaction Parameters in Bulk Solution Using Photobleaching: Reaction Limited Binding Regime Biophysical Journal, 60:596-610 (1991).
384. 1991 Vascular and Interstitial Transport in Tumors In: Tumor Blood Supply and Metabolic Microenvironment: Characterization and Therapeutic Implications, P. Vaupel and R.K. Jain, Eds., Fischer Publications, Stuttgart (1991).
385. 1991 Viscous Resistance to Blood Flow in the Tumor Microcirculation: Clinical Implications In: Tumor Blood Supply and Metabolic Microenvironment: Characterization and Therapeutic Implications, P. Vaupel and R.K. Jain, Eds., Fischer Publications, Stuttgart (1991).
386. 1991 Blood Flow Response to Hyperglycemia In: Tumor Blood Supply and Metabolic Microenvironment: Characterization and Therapeutic Implications, P. Vaupel and R.K. Jain, Eds., Fischer Publications, Stuttgart (1991).
387. 1991 Hemodynamic and Transport Barriers to the Treatment of Solid Tumors International Journal of Radiation Biology, 60:85-100 (1991).
388. 1991 Therapeutic Implications of Tumor Physiology Current Opinion in Oncology, 3:1105-1108 (1991).
389. 1990 Vascular and interstitial barriers to delivery of therapeutic agents in tumors Cancer and Metastasis Reviews, 9:253-266 (1990).
390. 1990 Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics Microvascular Research, 40:246-263 (1990).
391. 1990 Tumor physiology and antibody delivery Frontiers in Radiation Therapy and Oncology, 24:32- 46 (1990).
392. 1990 Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors Cancer Research, 50:814s-819s (1990).
393. 1990 Convection and diffusion measurements using fluorescence recovery after photobleaching and video image analysis: in vitro calibration and assessment Microvascular Research, 39:77-93 (1990).
394. 1990 Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues Cancer Research, 50:3487-3492 (1990).
395. 1990 Approaches to immunotherapy with defined populations of IL-2 cultured NK cells, immune T Cells or tumor infiltrating lymphocytes In: Biology and Clinical Applications of IL-2, R.C. Rees, Ed., Oxford University Press, London, Chapter 12, pp. 111-119 (1990).
396. 1990 Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy Cancer Research, 50:4478-4484 (1990). PubMed link
397. 1990 Quantification of transport and binding parameters using fluorescence recovery after photobleaching: potential for in vivo applications Biophysical Journal, 58:873-885 (1990).
398. 1989 Delivery of novel therapeutic agents in tumors: physiological barriers and strategies Journal of the National Cancer Institute, 81:570-576 (1989). PubMed link
399. 1989 Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure Cancer Research, 49:3506-3512 (1989).
400. 1989 Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity Cancer Research, 49:3513-3519 (1989).
401. 1989 Low deformability of LAK cells: a possible determinant of in vivo distribution Cancer Research, 49:3742-3746 (1989).
402. 1989 Direct measurement of interstitial diffusion and convection of albumin in normal and neoplastic tissues using fluorescence photobleaching PNAS, 86:5385-5389 (1989).
403. 1989 Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection Microvascular Research, 37:77-104 (1989).
404. 1988 Transvascular and interstitial transport in tumors Vascular Endothelium in Health and Disease, S. Chien (Ed.), pp 215-220, Elsevier, Amsterdam (1988).
405. 1988 Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure Cancer Research, 48:7022-7032 (1988). Pub Med link
406. 1988 Stability of thin films: characterization and applications in industrial and biological systems Thin Liquid Films, I.B. Ivanov, Ed., pp 497-568, M. Dekker, New York (1988).
407. 1988 Physiological response of tumors to hyperglycemia: characterization, significance, and role in hyperthermia International Journal of Hyperthermia, 4:223-250 (1988).
408. 1988 Effect of galactose on systemic hemodynamics and blood flow rate in normal and neoplastic tissues in rats Cancer Research, 48:1476-1480 (1988).
409. 1988 Blood flow and efferent blood pH of "tissue-isolated" Walker 256 carcinoma during hyperglycemia Cancer Research, 48:1201-1207 (1988).
410. 1988 Determinants of tumor blood flow: a review Cancer Research, 48:2641-2658 (1988).
411. 1988 Vascular permeability and interstitial diffusion in superfused tissues: a twodimensional model Microvascular Research, 36:108-115 (1988).
412. 1987 Interstitial transport in tumors Advances in Microcirculation, 13:266-284 (1987).
413. 1987 Vascular permeability and interstitial diffusion of macromolecules in the hamster cheek pouch: effects of vasoactive drugs Microvascular Research, 34:336-348 (1987).
414. 1987 Analysis of diffusive and convective recovery after photobleaching-uniform flow field Chemical Engineering Communications, 55:235-249 (1987).
415. 1987 Transport of molecules in the tumor interstitium: a review Cancer Research, 47:3038- 3050 (1987).
416. 1987 Dynamics of cancer cell interactions with microvasculature and interstitium, Biorheology, 24:117-125 (1987).
417. 1987 Effect of glucose and galactose on microcirculatory flow in normal and neoplastic tissues in rabbits Cancer Research, 47:371-377 (1987).
418. 1987 Effect of glucose and galactose on red blood cell membrane deformability International Journal of Microcirculation: Clinical and Experimental, 6:35-44 (1987).
419. 1987 Transport of molecules across tumor vasculature Cancer and Metastasis Reviews, 6:559- 594 (1987).
420. 1987 Tumor blood flow response to hyperthermia and pharmacological agents Radiation Research, E.M. Fieldman et al (eds.), Volume 2, pp 813-818, Taylor and Francis, London
421. 1987 Effect of Radiation on Interstitial Fluid Pressure and Oxygenation in a Human Colon Carcinoma Xenograft Cancer Research, 56:964-968 (1996).
422. 1986 Microvascular permeability of normal and neoplastic tissues Microvascular Research, 31:288-305 (1986). 30
423. 1986 Thin Liquid Film Phenomena at the ACS Meeting, Chicago, September 8-11, 1985. A.I.Ch.E. Symposium Series 252, 82 (1986).
424. 1986 Effect of hyperglycemia on systemic hemodynamics and blood flow rate in normal and neoplastic tissues in rats Cancer Research, 46:6299-6304 (1986).
425. 1986 Extravascular transport in normal and tumor tissues CRC Critical Reviews in Hematology and Oncology, 5:115-170 (1986).
426. 1986 Effect of glucose, galactose, and transmembrane potential on shear elastic modulus of erythrocyte membrane A.I.Ch.E. Symposium Series, 82:190-194 (1986).
427. 1986 Effect of transmembrane potential on the deformability of RBC's suspended in carbohydrate-saline solutions J. Colloid and Interface Science, 114:273-276 (1986).
428. 1985 Effect of hyperthermia on microvascular permeability of normal and neoplastic tissues International Journal of Microcirculation: Clinical and Experimental, 4:336-372 (1985).
429. 1985 Transport of macromolecules in tumor microcirculation Biotechnology Progress, 1:81-94 (1985).
430. 1985 Analysis of heat transfer and temperature distributions in tissues during local and whole body hyperthermia Heat Transfer in Medicine and Biology, A. Shitzer and R. Eberhart, Eds., Plenum Press, New York, Volume 2, Chapter 16, pp 3-54 (1985).
431. 1985 Stability of membrane systems modeled as multilayered viscoelastic thin films, J. Theor. Biol., 133:353-377 (1985).
432. 1984 Dielectric Properties of Solid Tumors during Normothermia and Hyperthermia IEEE Trans., Biomedical Engineering, BME-31:725-728 (1984).
433. 1984 Two-compartment model for plasma pharmacokinetics in individual blood vessels Journal of Pharmacokinetics and Biopharmaceutics, 12:451-461 (1984).
434. 1984 Continuous noninvasive monitoring of pH and temperature in rat Walker 256 carcinoma during normoglycemia and hyperglycemia Journal of the National Cancer Institute, 73:429-436 (1984).
435. 1984 Pore and fiber-matrix models for diffusive transport in normal and neoplastic tissues, Microvascular Research, 28:270-274 (1984).
436. 1984 Differential responses of normal and tumor microcirculation to hyperthermia Cancer Research, 44:605-612 (1984).
437. 1984 Extravascular diffusion in normal and neoplastic tissues Cancer Research, 44:238-244 (1984).
438. 1984 Plasma pharmacokinetics and interstitial diffusion of macromolecules in a normal capillary bed American Journal of Physiology, 246:H129-H137 (1984).
439. 1984 Thinning of films with deformable surfaces: diffusion-controlled surfactant transfer Chemical Engineering Science, 40:137-150 (1985)
440. 1984 Membrane stability Biochim. Biophys. Acta.- Reviews on Biomembranes, 779:437-468 (1984).
441. 1984 Tumor blood flow: characterization, modifications and role in hyperthermia IEEE Transactions in Sonics and Ultrasonics; Special Issue on Hyperthermia, SU-31:504- 526 (1984).
442. 1984 Mass and heat transfer in tumors: applications in detection and treatment Advances in Transport Processes, 3:205-339 (1984).
443. 1984 Surface effects in preparation of cell-size liposomes FEBS Letters, 176:398-400 (1984).
444. 1984 Stability of thin viscoelastic films between permeable membranes Journal of Colloid and Interface Science, 101:489-499 (1984).
445. 1983 Enhanced metastasis formation by combined hyperthermia and hyperglycemia in rats bearing Walker 256 carcinosarcoma Cancer Letters, 19:317-323 (1983).
446. 1983 Transport Phenomena in Biomedical Systems Proceedings of Biomedical Engineering Sessions at the 75th Annual Meeting of AIChE, Los Angeles, November 1982.A.I.Ch.E. Symposium Series 227, 79 (1983).
447. 1983 Macro- and Microscopic Modeling of Heat and Mass Transfer in Biological Systems Proceedings of NSF Workshop, Urbana-Champaign, April (1983).
448. 1983 Interstitial diffusion of macromolecules in normal and tumor capillary beds AIChE Symposium Series 227, 79:1-10 (1983).
449. 1983 Physiologically based pharmacokinetic modeling: principles and applications Journal of Pharmaceutical Sciences, 72:1103-1127 (1983).
450. 1983 Bioheat transfer: mathematical models of thermal systems Hyperthermia in Cancer Therapy, F.K. Storm, Ed., G.K. Hall and Co., Boston, Chapter 2, pp 9-46 (1983).
451. 1983 Mathematical models for microcirculatory changes during hyperthermia in normal and neoplastic tissues AIChE Symposium Series 227, 79:153-162 (1983). 29
452. 1982 Temperature distributions and thermal response in humans. II. Simulation of whole-body, regional and localized hyperthermia in cancer patients AIChE Symposium Series 227, 79:116- 123 (1983).
453. 1982 Microcirculatory flow changes during tissue growth Microvascular Research, 25:1-21 (1983).
454. 1982 Stability of thin viscoelastic films with applications to biological membrane deformation Annals of New York Academy of Sciences, 404:89-102, (1983).
455. 1982 Incorporating toxicology in the synthesis of industrial chemical complexes Chemical Engineering Communications, 17:151-170 (1982).
456. 1982 The linear, hydrodynamic stability of an interfacially perturbed, transversely isotropic, thin, planar viscoelastic film II. Extension of the theory to the study of the onset of small-scale cell membrane motions J. Colloid and Interface Science, 90:263-276 (1982).
457. 1982 The linear, hydrodynamic stability of an interfacially perturbed, transversely isotropic, thin, planar viscoelastic film. I. General formulation and a derivation of the dispersion equation J. Colloid and Interface Science, 90:233-262 (1982).
458. 1982 In vivo pharmacokinetics of triazinate in LI210 and W256 cells J. Pharmaceutical Sciences, 71:1102-1105 (1982).
459. 1982 Monitoring transport in the rabbit ear chamber Microvascular Research, 24:204-209 (1982).
460. 1982 Temperature distributions and thermal responses in humans. I. Simulations of various modes of whole-body hyperthermia in normal subjects Medical Physics, 9:506-513 (1982).
461. 1982 Temperature gradients and local perfusion in a mammary carcinoma J. National Cancer Institute, 68:519-533 (1982).
462. 1981 Kinetics of uptake, distribution and excretion of zinc in rats Annals of Biomedical Engineering, 9:347-361 (1981).
463. 1981 Dynamics of neovascularization in normal tissue Microvascular Research, 21:27-47 (1981).
464. 1980 Thermal Characteristics of Tumors: Applications in Detection and Treatment Annals of the New York Academy of Sciences, 335 (1980).
465. 1980 Mass transfer in tumors: characterization and applications in chemotherapy Advances in Cancer Research, 33:251-310 (1980).
466. 1980 Heat transfer in tumors: characterization and applications to thermography and hyperthermia Advances in Biomedical Engineering, edited by D.O. Cooney, Marcel Dekker, Inc., New York, Part I, Chapter 2, pp 59-91 (1980).
467. 1980 Thermal interactions between normal and neoplastic tissues in the rat, rabbit, swine and dog during hyperthermia, Medical Physics, 7:529-536 (1980).
468. 1980 Analysis of transient temperature distribution in a perfused medium Due to a spherical heat source with application to heat transfer in tumors: homogeneous and infinite medium Chemical Engineering Communications, 4:95-118 (1980).
469. 1980 Thinning and rupture of ring-shaped films J. Chemical Society, Faraday Transactions II, 76:250-266 (1980).
470. 1980 Stability of symmetric and unsymmetric, thin liquid films to short and long wavelength perturbations J. Colloid and Interface Science, 78:118-143
471. 1980 Preliminary model of streptozotocin metabolism in mice J. Pharmaceutical Science, 69:691-694 (1980).
472. 1980 Intratumour temperature distributions during hyperthermia, J. Thermal Biology, 5:127-130 (1980).
473. 1979 Transient temperature distributions in an infinite perfused medium due to a time-dependent, spherical heat source Trans. ASME J. Biomechanical Engineering, 101:82-86
474. 1979 Pharmacokinetics of methotrexate in solid tumors Pharmacokinetics and Biopharmaceutics, 7:181-194 (1979).
475. 1979 The role of surfactants on the coalescences of emulsion droplets Solution Chemistry of Surfactants, edited by K.A. Mittal, Plenum Press, New York, Volume 2, pp 817-840 (1979
476. 1979 Instability and rupture of thin liquid films Dynamics and Instability of Fluid Interfaces, edited by T.S. Sorensen, Springer-Verlag, New York, pp 140- 167 (1979).
477. 1979 Formation and thinning of thin liquid films Dynamics and Instability of Fluid Interfaces, edited by T.S. Sorensen, Springer-Verlag, New York, pp 120-139 (1979).
478. 1979 A semi-empirical model for cell kill kinetics during hyperthermia J. Thermal Biology, 4:257-258 (1979).
479. 1979 Temperature distributions in normal and neoplastic tissues during hyperthermia: a lumped parameter model J. Thermal Biology, 4:157-164 (1979).
480. 1979 Blood flow and heat transfer in Walker 256 mammary carcinoma J. National Cancer Institute, 62:927-933 (1979
481. 1978 Onset of microvilli in normal and neoplastic cells A.I.Ch.E. Symposium Series, Biorheology, 74:120-124 (1978).
482. 1978 Extracellular water measurements: organ tracer kinetics of bromide and sucrose in rats and man Am. J. Physiology, 235:254-264 (1978).
483. 1978 Pharmacokinetics of methotrexate in leukemia cells: effect of dose and mode of injection J. Pharmacokinetics and Biopharmaceutics, 6:487-503
484. 1978 Effect of inhomogeneities and finite boundaries on temperature distribution in a perfused medium with application to tumors Trans. ASME J. Biomechanical Engineering, 100:235-241 (1978).
485. 1977 Dynamics of drug transport in solid tumors: distributed parameter model J. Bioengineering, 1:313-329
486. 1976 Short term regulation of BOD upsets in an estuary," Trans. ASME J. Dynamic Systems, Measurement and Control, 98, Series G, 30-31 (1976).
487. 1976 Stability of stagnant viscous films on a solid surface J. Colloid and Interface Science, 54:108-116 (1976).
488. 1974 Temperature distributions in normal and neoplastic tissues during normothermia and hyperthermia Annals of New York Academy of Sciences, 335:48-64 (1980).
489. 1974 Spontaneous rupture of thin liquid films, J. Chemical Society, Faraday Transactions II, 70:132-147 (1974).


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.